OPTICROM - Sodium Cromoglycate 2% Eye Drops

Composition   Sodium Cromoglycate IP 2% w/v Benzalkonium Chloride   (As Preservative) 0.01% w/v Sterile Aqueous Base q.s. Dosage Form Ophthalmic Solution Pharmacology sodium cromoglycate inhibits the degranulation of sensitized mast cells which occurs after exposure to specific antigens. Sodium cromoglycate acts by inhibitating the release of histamine and various  membrane derived mediators of inflammation from mast cells. Indications Opticrom Eye Drops is indicated in the symptomatic treatment of vernal  keratoconjunctivitis, vernal conjunctivitis and vernal keratitis. Dosage & Administration 1-2 drops in each eye 4-6 times in a day at regular intervals. Recommended dosage should not be exceeded. Contraindications Hypersensitivity to any of the components of the formulation Precautions Pregnancy category BThe safety of Opticrom Eye Drops in pregnant patients has not been studied. The  potential benefits should be weighed against the risk before it is prescribed. Lactation Since it is not known if cromolyn sodium ophthalmic solution is distributed into milk in humans, the drug should be used with caution in lactating women Pediatric Use Safety and efficacy of cromolyn sodium ophthalmic solution in children younger than four years of age has not been establish Undesirable effects The most frequently reported undesirable effects are transient ocular stinging or burning upon instillation. Immediate hypersensitivity reactions have been reported rarely and include dyspnoea, edema and rash. Storage Store in a cool dry place. Protect from light. Presentation Opticrom is available in plastic bottle of 5 ml.